"Shapeshifting" Bowel Cancer Cells Spark Breakthrough in Treatment

Scientists have made a groundbreaking discovery that sheds light on the spread of aggressive forms of bowel cancer, with cells able to "shapeshift" into skin or muscle cells to evade detection and treatment. This finding has crucial implications for the treatment of a rapidly increasing number of young people being diagnosed with the disease. The study, conducted by the Cancer Research UK Scotland Centre and the University of Edinburgh, reveals a key mechanism behind the spread of bowel cancer: cellular plasticity.

Key Takeaways:

• Bowel cancer cells can lose their identity and resemble squamous cells, which form skin, or muscle cells, allowing them to spread aggressively.
• This adaptation enables cancer cells to tolerate harsher conditions, making them more "robust" and harder to treat.
• Cellular plasticity is a critical element in bowel cancer metastasis, or the spread of the disease.
• The study highlights the importance of preventing cellular plasticity to make current treatments more effective.
• Bowel cancer rates are rising in young people, with a recent study showing a significant increase in early-onset bowel cancer rates in adults aged 25 to 49 in 27 out of 50 countries studied.
• Scotland is disproportionately affected, with 4,000 people diagnosed with bowel cancer every year, according to Cancer Research UK.
• Researchers hope that understanding this mechanism will lead to more effective treatments and prevention strategies.

Statistics:

• 16,800 people in Britain die from bowel cancer every year.
• 1,700 people in Scotland die from bowel cancer every year.
• The American Cancer Society study published in The Lancet Oncology found that early-onset bowel cancer rates in adults aged 25 to 49 are rising in 27 out of 50 countries studied.
• The study found that the rates are increasing faster in young women in Scotland and England than in young men.
• 4,000 people are diagnosed with bowel cancer in Scotland every year.

Sources:

• Cancer Research UK Scotland Centre
• University of Edinburgh
• American Cancer Society
• The Lancet Oncology
• Cancer Research UK